IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Mylan Australia is a Proprietary Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry. In 2021 the company generated total revenue of $506,209,000 including sales and other revenue. In 2021 Mylan Australia had 752 employees including employees from all subsidiaries under the company's control. The Chief Executive of Mylan Australia is Mr Sylvain Vigneault whose official title is Country Manager. The Chairman of Mylan Australia is either not applicable or not available. Mylan Australia Holding Pty Ltd manufactures generic prescription and over-the-counter medicines under the Viatris name. The company operates a research and manufacturing centre in Carole Park, Queensland. Mylan Australia manufactures generic medication and its products are used to treat the following conditions: Allergy & Anaphylaxis Cardio-metabolic Dermatology Gastroenterology Primary Care Respiratory Women's Health Influenza Vaccines
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Mylan Australia Holding Pty Ltd includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Mylan Australia Holding Pty Ltd, trading as Mylan Australia, operates under the ABN 52 127 537 302 and was incorporated on 13 September 2007. Mylan Australia Holding Pty Ltd primarily operates in the Pharmaceuticals Wholesaling industry in Australia.
The Key Personnel chapter outlines the principal leadership positions within Mylan Australia Holding Pty Ltd, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
The Financials chapter presents Mylan Australia Holding Pty Ltd’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Mylan Australia Holding Pty Ltd operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
The Competitor Benchmarking chapter includes a comparative assessment of Mylan Australia Holding Pty Ltd’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
The Industries of Operation chapter outlines Mylan Australia Holding Pty Ltd’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
The Shareholders chapter provides a breakdown of the ownership structure of Mylan Australia Holding Pty Ltd, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Mylan Australia Holding Pty Ltd. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
The History chapter presents a overview of Mylan Australia Holding Pty Ltd’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Mylan Australia Holding Pty Ltd manufactures generic prescription and over-the-counter medicines under the Viatris name. The company operates a research and manufacturing centre in Carole Park, Queensland. Mylan Australia manufactures generic medication and its products are used to treat the following conditions: Allergy & Anaphylaxis Cardio-metabolic Dermatology Gastroenterology Primary Care Respiratory Women's Health Influenza Vaccines
Mylan Australia Holding Pty Ltd, trading as Mylan Australia, is a Private Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry in Australia.
Murray Cod Australia Limited company is based at 30 Hickson Road, Millers point, New South Wales, Australia.
The Country Manager of Mylan Australia Holding Pty Ltd is Not Available and the Country Manager is Sylvain Vigneault.
In 2025, Mylan Australia Holding Pty Ltd generated total revenue of approximately $506.2 million.